

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cell migration involved in heart development (GO:0060973) | 5.18782923 |
| 2 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 5.08018423 |
| 3 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 4.87271201 |
| 4 | Golgi transport vesicle coating (GO:0048200) | 4.82910715 |
| 5 | COPI coating of Golgi vesicle (GO:0048205) | 4.82910715 |
| 6 | positive regulation of extracellular matrix organization (GO:1903055) | 4.68858673 |
| 7 | tryptophan metabolic process (GO:0006568) | 4.46971936 |
| 8 | positive regulation of fibroblast migration (GO:0010763) | 4.45528703 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 4.41368138 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 4.41368138 |
| 11 | tryptophan catabolic process (GO:0006569) | 4.41368138 |
| 12 | aromatic amino acid family catabolic process (GO:0009074) | 4.22293293 |
| 13 | L-phenylalanine catabolic process (GO:0006559) | 4.13204198 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.13204198 |
| 15 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 4.06970446 |
| 16 | growth hormone receptor signaling pathway (GO:0060396) | 4.03923329 |
| 17 | cellular anion homeostasis (GO:0030002) | 3.98225156 |
| 18 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.92958698 |
| 19 | regulation of metalloenzyme activity (GO:0048552) | 3.84696491 |
| 20 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.76268105 |
| 21 | secondary heart field specification (GO:0003139) | 3.75225327 |
| 22 | heart field specification (GO:0003128) | 3.75225327 |
| 23 | cellular response to growth hormone stimulus (GO:0071378) | 3.73974263 |
| 24 | negative regulation of cell fate specification (GO:0009996) | 3.67864644 |
| 25 | urea cycle (GO:0000050) | 3.67203373 |
| 26 | urea metabolic process (GO:0019627) | 3.67203373 |
| 27 | phospholipid homeostasis (GO:0055091) | 3.62999619 |
| 28 | tyrosine metabolic process (GO:0006570) | 3.58341593 |
| 29 | reverse cholesterol transport (GO:0043691) | 3.56550764 |
| 30 | L-phenylalanine metabolic process (GO:0006558) | 3.55096573 |
| 31 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.55096573 |
| 32 | high-density lipoprotein particle remodeling (GO:0034375) | 3.54444695 |
| 33 | NAD biosynthetic process (GO:0009435) | 3.48171984 |
| 34 | kynurenine metabolic process (GO:0070189) | 3.48025212 |
| 35 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.47519826 |
| 36 | indolalkylamine metabolic process (GO:0006586) | 3.47461418 |
| 37 | homocysteine metabolic process (GO:0050667) | 3.43810200 |
| 38 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.42168521 |
| 39 | bile acid biosynthetic process (GO:0006699) | 3.40784179 |
| 40 | hemidesmosome assembly (GO:0031581) | 3.38493280 |
| 41 | diterpenoid biosynthetic process (GO:0016102) | 3.37969351 |
| 42 | alpha-linolenic acid metabolic process (GO:0036109) | 3.36876000 |
| 43 | protein carboxylation (GO:0018214) | 3.34332958 |
| 44 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.34332958 |
| 45 | phospholipid efflux (GO:0033700) | 3.32073936 |
| 46 | complement activation, alternative pathway (GO:0006957) | 3.31269195 |
| 47 | cell adhesion mediated by integrin (GO:0033627) | 3.31070377 |
| 48 | regulation of triglyceride catabolic process (GO:0010896) | 3.30080707 |
| 49 | cellular glucuronidation (GO:0052695) | 3.25190106 |
| 50 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.24812531 |
| 51 | desmosome organization (GO:0002934) | 3.24419941 |
| 52 | regulation of protein activation cascade (GO:2000257) | 3.20158639 |
| 53 | amine catabolic process (GO:0009310) | 3.18675367 |
| 54 | cellular biogenic amine catabolic process (GO:0042402) | 3.18675367 |
| 55 | mesodermal cell differentiation (GO:0048333) | 3.18670144 |
| 56 | COPII vesicle coating (GO:0048208) | 3.14837657 |
| 57 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.14729474 |
| 58 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.14221888 |
| 59 | nitrogen cycle metabolic process (GO:0071941) | 3.11606826 |
| 60 | aromatic amino acid family metabolic process (GO:0009072) | 3.04343018 |
| 61 | regulation of fibrinolysis (GO:0051917) | 3.04293490 |
| 62 | regulation of extracellular matrix organization (GO:1903053) | 3.03975965 |
| 63 | protein-lipid complex remodeling (GO:0034368) | 3.03851617 |
| 64 | macromolecular complex remodeling (GO:0034367) | 3.03851617 |
| 65 | plasma lipoprotein particle remodeling (GO:0034369) | 3.03851617 |
| 66 | cholesterol efflux (GO:0033344) | 3.01844381 |
| 67 | triglyceride homeostasis (GO:0070328) | 3.01759978 |
| 68 | acylglycerol homeostasis (GO:0055090) | 3.01759978 |
| 69 | midgut development (GO:0007494) | 2.98697295 |
| 70 | bile acid metabolic process (GO:0008206) | 2.97623704 |
| 71 | regulation of complement activation (GO:0030449) | 2.97246547 |
| 72 | regulation of cholesterol esterification (GO:0010872) | 2.96869289 |
| 73 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.95412648 |
| 74 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.95412648 |
| 75 | linoleic acid metabolic process (GO:0043651) | 2.94372777 |
| 76 | negative regulation of fibrinolysis (GO:0051918) | 2.91449864 |
| 77 | cardiac ventricle formation (GO:0003211) | 2.90227933 |
| 78 | negative regulation of lipase activity (GO:0060192) | 2.90192533 |
| 79 | low-density lipoprotein particle remodeling (GO:0034374) | 2.89112158 |
| 80 | epoxygenase P450 pathway (GO:0019373) | 2.87520257 |
| 81 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.86963970 |
| 82 | positive regulation of establishment of protein localization to plasma membrane (GO:0090004) | 2.83569729 |
| 83 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.83447670 |
| 84 | cell-substrate junction assembly (GO:0007044) | 2.82188580 |
| 85 | glucuronate metabolic process (GO:0019585) | 2.81019086 |
| 86 | uronic acid metabolic process (GO:0006063) | 2.81019086 |
| 87 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.80722582 |
| 88 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.76104535 |
| 89 | skin morphogenesis (GO:0043589) | 2.73724641 |
| 90 | negative regulation of protein activation cascade (GO:2000258) | 2.73581259 |
| 91 | regulation of bile acid biosynthetic process (GO:0070857) | 2.73501732 |
| 92 | lipoprotein metabolic process (GO:0042157) | 2.73443474 |
| 93 | positive regulation of protein localization to plasma membrane (GO:1903078) | 2.72993682 |
| 94 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.72638869 |
| 95 | amino-acid betaine metabolic process (GO:0006577) | 2.72470241 |
| 96 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.72453387 |
| 97 | plasma lipoprotein particle assembly (GO:0034377) | 2.71783334 |
| 98 | positive regulation of lipid catabolic process (GO:0050996) | 2.71703365 |
| 99 | regulation of glucokinase activity (GO:0033131) | 2.71404666 |
| 100 | regulation of hexokinase activity (GO:1903299) | 2.71404666 |
| 101 | glyoxylate metabolic process (GO:0046487) | 2.71327628 |
| 102 | valine metabolic process (GO:0006573) | 2.71079975 |
| 103 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.70827708 |
| 104 | coenzyme catabolic process (GO:0009109) | 2.70139470 |
| 105 | regulation of endothelial cell apoptotic process (GO:2000351) | 2.69360147 |
| 106 | imidazole-containing compound metabolic process (GO:0052803) | 2.64994075 |
| 107 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.63455479 |
| 108 | alpha-amino acid catabolic process (GO:1901606) | 2.63401487 |
| 109 | cardiac chamber formation (GO:0003207) | 2.63281257 |
| 110 | response to interferon-alpha (GO:0035455) | 2.62537402 |
| 111 | vesicle coating (GO:0006901) | 2.61168067 |
| 112 | plasma lipoprotein particle clearance (GO:0034381) | 2.60949292 |
| 113 | omega-hydroxylase P450 pathway (GO:0097267) | 2.58945345 |
| 114 | regulation of extracellular matrix disassembly (GO:0010715) | 2.57658561 |
| 115 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.56705126 |
| 116 | positive regulation of fatty acid oxidation (GO:0046321) | 2.56272915 |
| 117 | DNA integration (GO:0015074) | 2.55389304 |
| 118 | plasma lipoprotein particle organization (GO:0071827) | 2.54066324 |
| 119 | cell-substrate adherens junction assembly (GO:0007045) | 2.51606705 |
| 120 | focal adhesion assembly (GO:0048041) | 2.51606705 |
| 121 | specification of organ identity (GO:0010092) | 2.51365359 |
| 122 | regulation of sequestering of triglyceride (GO:0010889) | 2.50715139 |
| 123 | fibroblast migration (GO:0010761) | 2.49882682 |
| 124 | cholesterol homeostasis (GO:0042632) | 2.49032525 |
| 125 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 2.47856766 |
| 126 | proline biosynthetic process (GO:0006561) | 2.46963333 |
| 127 | positive regulation of interferon-alpha production (GO:0032727) | 2.46240975 |
| 128 | bile acid and bile salt transport (GO:0015721) | 2.45794750 |
| 129 | regulation of apoptotic cell clearance (GO:2000425) | 2.43625188 |
| 130 | intestinal cholesterol absorption (GO:0030299) | 2.43308928 |
| 131 | cell migration involved in gastrulation (GO:0042074) | 2.42562586 |
| 132 | blood coagulation, intrinsic pathway (GO:0007597) | 2.42071642 |
| 133 | exogenous drug catabolic process (GO:0042738) | 2.41983400 |
| 134 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.41956147 |
| 135 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.41898996 |
| 136 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.41595601 |
| 137 | sterol homeostasis (GO:0055092) | 2.40922938 |
| 138 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.38225854 |
| 139 | histone H3-K4 trimethylation (GO:0080182) | 2.37901223 |
| 140 | purine nucleotide transport (GO:0015865) | 2.37362793 |
| 141 | chondrocyte proliferation (GO:0035988) | 2.36673647 |
| 142 | negative regulation of complement activation (GO:0045916) | 2.36428896 |
| 143 | purine ribonucleotide transport (GO:0015868) | 2.35320540 |
| 144 | biotin metabolic process (GO:0006768) | 2.35227914 |
| 145 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.34968652 |
| 146 | sulfur amino acid catabolic process (GO:0000098) | 2.34440624 |
| 147 | replicative senescence (GO:0090399) | 2.33293440 |
| 148 | fibrinolysis (GO:0042730) | 2.32583127 |
| 149 | collagen fibril organization (GO:0030199) | 2.32375963 |
| 150 | negative regulation of lipid storage (GO:0010888) | 2.32079123 |
| 151 | semaphorin-plexin signaling pathway (GO:0071526) | 2.31583230 |
| 152 | arginine metabolic process (GO:0006525) | 2.30584885 |
| 153 | regulation of plasminogen activation (GO:0010755) | 2.30237091 |
| 154 | protein activation cascade (GO:0072376) | 2.30055390 |
| 155 | daunorubicin metabolic process (GO:0044597) | 2.29534389 |
| 156 | polyketide metabolic process (GO:0030638) | 2.29534389 |
| 157 | doxorubicin metabolic process (GO:0044598) | 2.29534389 |
| 158 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 2.29104741 |
| 159 | drug catabolic process (GO:0042737) | 2.28939365 |
| 160 | regulation of fibroblast migration (GO:0010762) | 2.27842275 |
| 161 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.26317451 |
| 162 | primary alcohol catabolic process (GO:0034310) | 2.22571433 |
| 163 | macroautophagy (GO:0016236) | 2.22489582 |
| 164 | response to growth hormone (GO:0060416) | 2.19502275 |
| 165 | positive regulation of ERBB signaling pathway (GO:1901186) | 2.19449183 |
| 166 | negative regulation of fatty acid transport (GO:2000192) | 2.19107484 |
| 167 | actin filament depolymerization (GO:0030042) | 2.17998326 |
| 168 | iron ion import (GO:0097286) | 2.17836947 |
| 169 | type B pancreatic cell proliferation (GO:0044342) | 2.16134149 |
| 170 | necroptotic process (GO:0070266) | 2.15814413 |
| 171 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.15706616 |
| 172 | adherens junction assembly (GO:0034333) | 2.15203882 |
| 173 | regulation of substrate adhesion-dependent cell spreading (GO:1900024) | 2.14954049 |
| 174 | proline metabolic process (GO:0006560) | 2.14842255 |
| 175 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.11978576 |
| 176 | retinal metabolic process (GO:0042574) | 2.11420957 |
| 177 | smooth muscle tissue development (GO:0048745) | 2.09591000 |
| 178 | regulation of establishment of protein localization to plasma membrane (GO:0090003) | 2.09354665 |
| 179 | ethanol oxidation (GO:0006069) | 2.09179820 |
| 180 | regulation of protein localization to plasma membrane (GO:1903076) | 2.08583626 |
| 181 | negative regulation of cell-matrix adhesion (GO:0001953) | 2.08046748 |
| 182 | lymphangiogenesis (GO:0001946) | 2.07952717 |
| 183 | negative regulation of stem cell proliferation (GO:2000647) | 2.07776479 |
| 184 | endodermal cell differentiation (GO:0035987) | 2.07425621 |
| 185 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.07095468 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.26540156 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.88773067 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.68545472 |
| 4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.48878975 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.36977850 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.31857039 |
| 7 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.24236757 |
| 8 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.97449773 |
| 9 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.73153875 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.69399762 |
| 11 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.61446497 |
| 12 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.58107809 |
| 13 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.57324109 |
| 14 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.49448527 |
| 15 | CJUN_26792858_Chip-Seq_BT549_Human | 2.23614045 |
| 16 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.22093831 |
| 17 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.21834154 |
| 18 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.17338246 |
| 19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.13526273 |
| 20 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.12684340 |
| 21 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.11616347 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 2.11379251 |
| 23 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.10289041 |
| 24 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.09200215 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.08931677 |
| 26 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 2.05418571 |
| 27 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.02688425 |
| 28 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.01560955 |
| 29 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.98152551 |
| 30 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.95596781 |
| 31 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.95330954 |
| 32 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.95168404 |
| 33 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.91399045 |
| 34 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.90756806 |
| 35 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.90655898 |
| 36 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.89696249 |
| 37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.89147135 |
| 38 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.86742054 |
| 39 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.84009818 |
| 40 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.82234476 |
| 41 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.80762190 |
| 42 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.79669831 |
| 43 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.77898513 |
| 44 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.77664973 |
| 45 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.76510033 |
| 46 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.73163086 |
| 47 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.71051209 |
| 48 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.70971784 |
| 49 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.69168850 |
| 50 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.67304139 |
| 51 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.67199597 |
| 52 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.66697381 |
| 53 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.65803510 |
| 54 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.63165899 |
| 55 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.63165899 |
| 56 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.62656854 |
| 57 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.61683430 |
| 58 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.58930742 |
| 59 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.58181807 |
| 60 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.58128168 |
| 61 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.57568458 |
| 62 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.56859768 |
| 63 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.55274973 |
| 64 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.55076280 |
| 65 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.54089271 |
| 66 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.52921161 |
| 67 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.52676568 |
| 68 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.51712133 |
| 69 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.50378866 |
| 70 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.50209090 |
| 71 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.49587531 |
| 72 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.49389793 |
| 73 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.47907906 |
| 74 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.46956122 |
| 75 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.46157834 |
| 76 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.44729627 |
| 77 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41394717 |
| 78 | P300_19829295_ChIP-Seq_ESCs_Human | 1.40624797 |
| 79 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.39229376 |
| 80 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.38514396 |
| 81 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.38238418 |
| 82 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.38191812 |
| 83 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.38191812 |
| 84 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.37618874 |
| 85 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.37055494 |
| 86 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.36701311 |
| 87 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.36610067 |
| 88 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.36087754 |
| 89 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.35518956 |
| 90 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.35243833 |
| 91 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.35232224 |
| 92 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.34206770 |
| 93 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.33542252 |
| 94 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.32770560 |
| 95 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.32246646 |
| 96 | * PU1_27457419_Chip-Seq_LIVER_Mouse | 1.30727426 |
| 97 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.29460774 |
| 98 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.29022373 |
| 99 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.28761505 |
| 100 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.28116184 |
| 101 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.28044518 |
| 102 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.27903346 |
| 103 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.27848327 |
| 104 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.27259032 |
| 105 | EWS_26573619_Chip-Seq_HEK293_Human | 1.26953864 |
| 106 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.26856328 |
| 107 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.25997629 |
| 108 | TP53_16413492_ChIP-PET_HCT116_Human | 1.25684189 |
| 109 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.25678576 |
| 110 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.24915429 |
| 111 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.24677266 |
| 112 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.22649622 |
| 113 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.22100174 |
| 114 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.21837294 |
| 115 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21170215 |
| 116 | * ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.19214092 |
| 117 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.18783738 |
| 118 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.18513660 |
| 119 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.18228972 |
| 120 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.15988245 |
| 121 | * ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.15727324 |
| 122 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.15104421 |
| 123 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.14219963 |
| 124 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.14056089 |
| 125 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13662721 |
| 126 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.13089882 |
| 127 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.12094917 |
| 128 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.11897440 |
| 129 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.11624853 |
| 130 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10979973 |
| 131 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.10930905 |
| 132 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.10930905 |
| 133 | * SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.10772169 |
| 134 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.10627935 |
| 135 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.08788420 |
| 136 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08788420 |
| 137 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.08183887 |
| 138 | * KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.07760488 |
| 139 | * CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.07306904 |
| 140 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.06775847 |
| 141 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.06535069 |
| 142 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05456656 |
| 143 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.04650951 |
| 144 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03768096 |
| 145 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.03722459 |
| 146 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.02900002 |
| 147 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.02728346 |
| 148 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.01760370 |
| 149 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01577415 |
| 150 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.01195589 |
| 151 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.00658862 |
| 152 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00627805 |
| 153 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.00486378 |
| 154 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.00328361 |
| 155 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.00312574 |
| 156 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.99980758 |
| 157 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.99060873 |
| 158 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98441784 |
| 159 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97738146 |
| 160 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.95791588 |
| 161 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.94195432 |
| 162 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93939862 |
| 163 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.93618250 |
| 164 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.92613349 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.06918842 |
| 2 | MP0005360_urolithiasis | 4.27861415 |
| 3 | MP0005365_abnormal_bile_salt | 3.84230360 |
| 4 | MP0009697_abnormal_copulation | 3.62307380 |
| 5 | MP0003950_abnormal_plasma_membrane | 3.61748416 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.49630798 |
| 7 | MP0009780_abnormal_chondrocyte_physiolo | 3.49167394 |
| 8 | MP0002234_abnormal_pharynx_morphology | 3.24319740 |
| 9 | MP0000569_abnormal_digit_pigmentation | 3.12563887 |
| 10 | MP0003252_abnormal_bile_duct | 3.10629122 |
| 11 | MP0004272_abnormal_basement_membrane | 3.00899237 |
| 12 | MP0006054_spinal_hemorrhage | 2.76217002 |
| 13 | MP0000566_synostosis | 2.72822142 |
| 14 | MP0010234_abnormal_vibrissa_follicle | 2.50094743 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.36106924 |
| 16 | MP0003705_abnormal_hypodermis_morpholog | 2.29469078 |
| 17 | MP0005171_absent_coat_pigmentation | 2.10981691 |
| 18 | MP0000013_abnormal_adipose_tissue | 1.99267856 |
| 19 | MP0010329_abnormal_lipoprotein_level | 1.97014969 |
| 20 | MP0003941_abnormal_skin_development | 1.92114175 |
| 21 | MP0003566_abnormal_cell_adhesion | 1.91597926 |
| 22 | MP0008438_abnormal_cutaneous_collagen | 1.89243742 |
| 23 | MP0005023_abnormal_wound_healing | 1.87593042 |
| 24 | MP0002938_white_spotting | 1.87158251 |
| 25 | MP0005503_abnormal_tendon_morphology | 1.77627532 |
| 26 | MP0003868_abnormal_feces_composition | 1.76173249 |
| 27 | MP0001346_abnormal_lacrimal_gland | 1.66468212 |
| 28 | MP0000751_myopathy | 1.58532929 |
| 29 | MP0001835_abnormal_antigen_presentation | 1.58299535 |
| 30 | MP0002876_abnormal_thyroid_physiology | 1.55887670 |
| 31 | MP0000003_abnormal_adipose_tissue | 1.53989995 |
| 32 | MP0005666_abnormal_adipose_tissue | 1.53529140 |
| 33 | MP0005670_abnormal_white_adipose | 1.52069846 |
| 34 | MP0002138_abnormal_hepatobiliary_system | 1.48192366 |
| 35 | MP0005375_adipose_tissue_phenotype | 1.45405214 |
| 36 | MP0005408_hypopigmentation | 1.44389335 |
| 37 | MP0002254_reproductive_system_inflammat | 1.43984892 |
| 38 | MP0001666_abnormal_nutrient_absorption | 1.43818915 |
| 39 | MP0001661_extended_life_span | 1.43272963 |
| 40 | MP0005409_darkened_coat_color | 1.42773550 |
| 41 | MP0005647_abnormal_sex_gland | 1.42188871 |
| 42 | MP0001299_abnormal_eye_distance/ | 1.38911511 |
| 43 | MP0003279_aneurysm | 1.38142617 |
| 44 | MP0004381_abnormal_hair_follicle | 1.36053398 |
| 45 | MP0002896_abnormal_bone_mineralization | 1.34249653 |
| 46 | MP0004233_abnormal_muscle_weight | 1.29327478 |
| 47 | MP0003195_calcinosis | 1.27603997 |
| 48 | MP0004264_abnormal_extraembryonic_tissu | 1.27127944 |
| 49 | MP0005332_abnormal_amino_acid | 1.26942731 |
| 50 | MP0001764_abnormal_homeostasis | 1.25422761 |
| 51 | MP0005058_abnormal_lysosome_morphology | 1.25313971 |
| 52 | MP0005248_abnormal_Harderian_gland | 1.25112958 |
| 53 | MP0000371_diluted_coat_color | 1.24644011 |
| 54 | MP0003385_abnormal_body_wall | 1.22987599 |
| 55 | MP0010352_gastrointestinal_tract_polyps | 1.22254848 |
| 56 | MP0000372_irregular_coat_pigmentation | 1.21398414 |
| 57 | MP0005623_abnormal_meninges_morphology | 1.20185668 |
| 58 | MP0001188_hyperpigmentation | 1.20037431 |
| 59 | MP0005083_abnormal_biliary_tract | 1.19523394 |
| 60 | MP0002089_abnormal_postnatal_growth/wei | 1.18981685 |
| 61 | MP0000733_abnormal_muscle_development | 1.18871209 |
| 62 | MP0009764_decreased_sensitivity_to | 1.17490909 |
| 63 | MP0005379_endocrine/exocrine_gland_phen | 1.17055650 |
| 64 | MP0003787_abnormal_imprinting | 1.16236194 |
| 65 | MP0000427_abnormal_hair_cycle | 1.15696393 |
| 66 | MP0002108_abnormal_muscle_morphology | 1.15201418 |
| 67 | MP0003091_abnormal_cell_migration | 1.14241535 |
| 68 | MP0005075_abnormal_melanosome_morpholog | 1.13517069 |
| 69 | MP0010678_abnormal_skin_adnexa | 1.13009344 |
| 70 | MP0004019_abnormal_vitamin_homeostasis | 1.11407556 |
| 71 | MP0001879_abnormal_lymphatic_vessel | 1.10391558 |
| 72 | MP0000383_abnormal_hair_follicle | 1.09300867 |
| 73 | MP0002638_abnormal_pupillary_reflex | 1.06642202 |
| 74 | MP0000609_abnormal_liver_physiology | 1.04350808 |
| 75 | MP0009763_increased_sensitivity_to | 1.02491603 |
| 76 | MP0000767_abnormal_smooth_muscle | 1.01461031 |
| 77 | MP0002249_abnormal_larynx_morphology | 1.01224061 |
| 78 | MP0005367_renal/urinary_system_phenotyp | 1.01010160 |
| 79 | MP0000516_abnormal_urinary_system | 1.01010160 |
| 80 | MP0002095_abnormal_skin_pigmentation | 0.98458993 |
| 81 | MP0002060_abnormal_skin_morphology | 0.97943467 |
| 82 | MP0008007_abnormal_cellular_replicative | 0.97861899 |
| 83 | MP0001958_emphysema | 0.97710279 |
| 84 | MP0000015_abnormal_ear_pigmentation | 0.97377158 |
| 85 | MP0000749_muscle_degeneration | 0.97312107 |
| 86 | MP0010368_abnormal_lymphatic_system | 0.97145241 |
| 87 | MP0002118_abnormal_lipid_homeostasis | 0.96038323 |
| 88 | MP0008775_abnormal_heart_ventricle | 0.94209745 |
| 89 | MP0010030_abnormal_orbit_morphology | 0.92338117 |
| 90 | MP0002396_abnormal_hematopoietic_system | 0.92249544 |
| 91 | MP0002166_altered_tumor_susceptibility | 0.92177237 |
| 92 | MP0001186_pigmentation_phenotype | 0.92011277 |
| 93 | MP0005220_abnormal_exocrine_pancreas | 0.91959650 |
| 94 | MP0004087_abnormal_muscle_fiber | 0.91551161 |
| 95 | MP0001324_abnormal_eye_pigmentation | 0.91494302 |
| 96 | MP0003183_abnormal_peptide_metabolism | 0.91405185 |
| 97 | MP0009250_abnormal_appendicular_skeleto | 0.90853125 |
| 98 | MP0000534_abnormal_ureter_morphology | 0.90451837 |
| 99 | MP0005164_abnormal_response_to | 0.90012659 |
| 100 | MP0002177_abnormal_outer_ear | 0.89697834 |
| 101 | MP0000762_abnormal_tongue_morphology | 0.88725636 |
| 102 | MP0001873_stomach_inflammation | 0.88177108 |
| 103 | MP0002075_abnormal_coat/hair_pigmentati | 0.87930608 |
| 104 | MP0009384_cardiac_valve_regurgitation | 0.87428090 |
| 105 | MP0004134_abnormal_chest_morphology | 0.86446295 |
| 106 | MP0004782_abnormal_surfactant_physiolog | 0.85573029 |
| 107 | MP0003115_abnormal_respiratory_system | 0.85418057 |
| 108 | MP0003943_abnormal_hepatobiliary_system | 0.85410768 |
| 109 | MP0002932_abnormal_joint_morphology | 0.85396488 |
| 110 | MP0002282_abnormal_trachea_morphology | 0.85295017 |
| 111 | MP0001177_atelectasis | 0.85004154 |
| 112 | MP0008057_abnormal_DNA_replication | 0.84000942 |
| 113 | MP0005275_abnormal_skin_tensile | 0.82890678 |
| 114 | MP0002109_abnormal_limb_morphology | 0.82734678 |
| 115 | MP0002971_abnormal_brown_adipose | 0.82445565 |
| 116 | MP0009785_altered_susceptibility_to | 0.82441701 |
| 117 | MP0005187_abnormal_penis_morphology | 0.82072210 |
| 118 | MP0009840_abnormal_foam_cell | 0.81333684 |
| 119 | MP0002419_abnormal_innate_immunity | 0.80165223 |
| 120 | MP0005174_abnormal_tail_pigmentation | 0.79938821 |
| 121 | MP0004084_abnormal_cardiac_muscle | 0.79428003 |
| 122 | MP0001119_abnormal_female_reproductive | 0.79015758 |
| 123 | MP0002928_abnormal_bile_duct | 0.78794053 |
| 124 | MP0000579_abnormal_nail_morphology | 0.78793168 |
| 125 | MP0003011_delayed_dark_adaptation | 0.78681498 |
| 126 | MP0000627_abnormal_mammary_gland | 0.78571675 |
| 127 | MP0004510_myositis | 0.78527992 |
| 128 | MP0005197_abnormal_uvea_morphology | 0.78500778 |
| 129 | MP0003191_abnormal_cellular_cholesterol | 0.78385143 |
| 130 | MP0002277_abnormal_respiratory_mucosa | 0.78380286 |
| 131 | MP0003172_abnormal_lysosome_physiology | 0.78288696 |
| 132 | MP0002163_abnormal_gland_morphology | 0.77977514 |
| 133 | MP0005508_abnormal_skeleton_morphology | 0.77856253 |
| 134 | MP0001853_heart_inflammation | 0.77492361 |
| 135 | MP0005257_abnormal_intraocular_pressure | 0.77227616 |
| 136 | MP0003935_abnormal_craniofacial_develop | 0.77148677 |
| 137 | MP0005395_other_phenotype | 0.76960447 |
| 138 | MP0004130_abnormal_muscle_cell | 0.76819301 |
| 139 | MP0006138_congestive_heart_failure | 0.76777135 |
| 140 | MP0002132_abnormal_respiratory_system | 0.76284417 |
| 141 | MP0000538_abnormal_urinary_bladder | 0.76054332 |
| 142 | MP0005334_abnormal_fat_pad | 0.76036332 |
| 143 | MP0005330_cardiomyopathy | 0.75840300 |
| 144 | MP0002115_abnormal_skeleton_extremities | 0.75601560 |
| 145 | MP0002168_other_aberrant_phenotype | 0.75297514 |
| 146 | MP0001614_abnormal_blood_vessel | 0.73843920 |
| 147 | MP0003942_abnormal_urinary_system | 0.73361938 |
| 148 | MP0008058_abnormal_DNA_repair | 0.72706012 |
| 149 | MP0000537_abnormal_urethra_morphology | 0.72456062 |
| 150 | MP0002909_abnormal_adrenal_gland | 0.72337558 |
| 151 | MP0003937_abnormal_limbs/digits/tail_de | 0.71633835 |
| 152 | MP0005319_abnormal_enzyme/_coenzyme | 0.71547872 |
| 153 | MP0002006_tumorigenesis | 0.71224065 |
| 154 | MP0001243_abnormal_dermal_layer | 0.70784894 |
| 155 | MP0000598_abnormal_liver_morphology | 0.70707235 |
| 156 | MP0002128_abnormal_blood_circulation | 0.69986615 |
| 157 | MP0002295_abnormal_pulmonary_circulatio | 0.69741314 |
| 158 | MP0000432_abnormal_head_morphology | 0.69452108 |
| 159 | MP0002269_muscular_atrophy | 0.68575197 |
| 160 | MP0005387_immune_system_phenotype | 0.68067546 |
| 161 | MP0001790_abnormal_immune_system | 0.68067546 |
| 162 | MP0000163_abnormal_cartilage_morphology | 0.67948983 |
| 163 | MP0005464_abnormal_platelet_physiology | 0.67652678 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glucose intolerance (HP:0000833) | 4.54358983 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 4.27874697 |
| 3 | Protrusio acetabuli (HP:0003179) | 3.89609756 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 3.69145475 |
| 5 | Chronic hepatic failure (HP:0100626) | 3.64458720 |
| 6 | Renal cortical cysts (HP:0000803) | 3.63067118 |
| 7 | Hypoplasia of the iris (HP:0007676) | 3.58882517 |
| 8 | Joint hemorrhage (HP:0005261) | 3.58227326 |
| 9 | Premature rupture of membranes (HP:0001788) | 3.51218881 |
| 10 | Cervical subluxation (HP:0003308) | 3.49518265 |
| 11 | Conjugated hyperbilirubinemia (HP:0002908) | 3.45756254 |
| 12 | Abnormal glucose tolerance (HP:0001952) | 3.45544018 |
| 13 | Epidermoid cyst (HP:0200040) | 3.44532440 |
| 14 | Enlarged kidneys (HP:0000105) | 3.37127281 |
| 15 | Aortic dissection (HP:0002647) | 3.25005900 |
| 16 | Autoimmune thrombocytopenia (HP:0001973) | 3.21496784 |
| 17 | Vascular tortuosity (HP:0004948) | 3.20001572 |
| 18 | Arterial tortuosity (HP:0005116) | 3.19031970 |
| 19 | Enlarged epiphyses (HP:0010580) | 3.18821403 |
| 20 | Aortic aneurysm (HP:0004942) | 3.13646325 |
| 21 | Abnormality of methionine metabolism (HP:0010901) | 3.11972628 |
| 22 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.08977989 |
| 23 | Abnormality of incisor morphology (HP:0011063) | 3.06032731 |
| 24 | Deep venous thrombosis (HP:0002625) | 3.05315567 |
| 25 | Atrophic scars (HP:0001075) | 3.05175357 |
| 26 | Sparse lateral eyebrow (HP:0005338) | 3.01858525 |
| 27 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.99387000 |
| 28 | Abnormality of the fingertips (HP:0001211) | 2.97372192 |
| 29 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.92976209 |
| 30 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.89217706 |
| 31 | Hyperglycemia (HP:0003074) | 2.78463874 |
| 32 | Chin dimple (HP:0010751) | 2.73528302 |
| 33 | Hypobetalipoproteinemia (HP:0003563) | 2.71645621 |
| 34 | Autoimmune hemolytic anemia (HP:0001890) | 2.70211003 |
| 35 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.68778360 |
| 36 | Premature skin wrinkling (HP:0100678) | 2.68680299 |
| 37 | Cardiovascular calcification (HP:0011915) | 2.66253839 |
| 38 | Xanthomatosis (HP:0000991) | 2.65782411 |
| 39 | Hepatoblastoma (HP:0002884) | 2.64352951 |
| 40 | Hypoglycemic coma (HP:0001325) | 2.61927488 |
| 41 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.60612181 |
| 42 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.60572995 |
| 43 | Abnormality of the renal cortex (HP:0011035) | 2.60279504 |
| 44 | Neonatal hypoglycemia (HP:0001998) | 2.59013010 |
| 45 | Abnormality of complement system (HP:0005339) | 2.57123187 |
| 46 | Tubulointerstitial nephritis (HP:0001970) | 2.54471601 |
| 47 | Gingival bleeding (HP:0000225) | 2.53023681 |
| 48 | Abnormality of the common coagulation pathway (HP:0010990) | 2.51263428 |
| 49 | Hyperlipoproteinemia (HP:0010980) | 2.49433820 |
| 50 | Prostate neoplasm (HP:0100787) | 2.49211251 |
| 51 | Shallow orbits (HP:0000586) | 2.47193209 |
| 52 | Abnormality of carpal bone ossification (HP:0006257) | 2.41285855 |
| 53 | Alveolar cell carcinoma (HP:0006519) | 2.39385472 |
| 54 | Neonatal short-limb short stature (HP:0008921) | 2.39134562 |
| 55 | Anterior segment dysgenesis (HP:0007700) | 2.35751237 |
| 56 | Vascular calcification (HP:0004934) | 2.32627943 |
| 57 | Hydroxyprolinuria (HP:0003080) | 2.31648587 |
| 58 | Abnormality of proline metabolism (HP:0010907) | 2.31648587 |
| 59 | Hypolipoproteinemia (HP:0010981) | 2.30481259 |
| 60 | Syringomyelia (HP:0003396) | 2.30032812 |
| 61 | Spinal cord lesions (HP:0100561) | 2.30032812 |
| 62 | Hypoalphalipoproteinemia (HP:0003233) | 2.28901526 |
| 63 | Fair hair (HP:0002286) | 2.28036701 |
| 64 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.26028539 |
| 65 | Complement deficiency (HP:0004431) | 2.24235596 |
| 66 | Abnormality of the intrinsic pathway (HP:0010989) | 2.23514085 |
| 67 | Pigmentary retinal degeneration (HP:0001146) | 2.21877349 |
| 68 | Hypoglycemic seizures (HP:0002173) | 2.21176702 |
| 69 | Opisthotonus (HP:0002179) | 2.19440494 |
| 70 | Chronic diarrhea (HP:0002028) | 2.18691751 |
| 71 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.18670879 |
| 72 | Insulin resistance (HP:0000855) | 2.18347119 |
| 73 | Abnormal biliary tract physiology (HP:0012439) | 2.18108669 |
| 74 | Bile duct proliferation (HP:0001408) | 2.18108669 |
| 75 | Cerebral aneurysm (HP:0004944) | 2.18083693 |
| 76 | Short nail (HP:0001799) | 2.16725843 |
| 77 | Abnormality of homocysteine metabolism (HP:0010919) | 2.15513334 |
| 78 | Homocystinuria (HP:0002156) | 2.15513334 |
| 79 | Chromsome breakage (HP:0040012) | 2.14797022 |
| 80 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.12168324 |
| 81 | Blue sclerae (HP:0000592) | 2.11321755 |
| 82 | Glomerulonephritis (HP:0000099) | 2.11129092 |
| 83 | Dry hair (HP:0011359) | 2.10720414 |
| 84 | Striae distensae (HP:0001065) | 2.09629658 |
| 85 | Hypercholesterolemia (HP:0003124) | 2.09082642 |
| 86 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.08934514 |
| 87 | Flat acetabular roof (HP:0003180) | 2.08748795 |
| 88 | Abnormal ossification of hand bones (HP:0005921) | 2.07500359 |
| 89 | Spondylolisthesis (HP:0003302) | 2.06623554 |
| 90 | Abnormal hand bone ossification (HP:0010660) | 2.05514948 |
| 91 | Ovoid vertebral bodies (HP:0003300) | 2.05264574 |
| 92 | White forelock (HP:0002211) | 2.05013599 |
| 93 | Thin bony cortex (HP:0002753) | 2.04932197 |
| 94 | Fat malabsorption (HP:0002630) | 2.03809834 |
| 95 | Lip pit (HP:0100267) | 2.03481992 |
| 96 | Joint laxity (HP:0001388) | 2.02278338 |
| 97 | Aneurysm (HP:0002617) | 2.00675118 |
| 98 | Wormian bones (HP:0002645) | 2.00520204 |
| 99 | Advanced eruption of teeth (HP:0006288) | 2.00024675 |
| 100 | Tibial bowing (HP:0002982) | 2.00017282 |
| 101 | Right ventricular cardiomyopathy (HP:0011663) | 1.99477490 |
| 102 | Portal hypertension (HP:0001409) | 1.97337146 |
| 103 | Mesomelia (HP:0003027) | 1.96093010 |
| 104 | Bell-shaped thorax (HP:0001591) | 1.95686053 |
| 105 | Abnormality of the columella (HP:0009929) | 1.95600929 |
| 106 | Generalized aminoaciduria (HP:0002909) | 1.95470289 |
| 107 | Soft skin (HP:0000977) | 1.94532212 |
| 108 | Popliteal pterygium (HP:0009756) | 1.94267563 |
| 109 | Abnormality of the anterior chamber (HP:0000593) | 1.93588637 |
| 110 | Aortic regurgitation (HP:0001659) | 1.92492857 |
| 111 | Myocardial infarction (HP:0001658) | 1.91849876 |
| 112 | Follicular hyperkeratosis (HP:0007502) | 1.90766208 |
| 113 | Submucous cleft hard palate (HP:0000176) | 1.90094038 |
| 114 | Abnormality of the parietal bone (HP:0002696) | 1.88893420 |
| 115 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.88876291 |
| 116 | Ankle contracture (HP:0006466) | 1.88742107 |
| 117 | Ectopic kidney (HP:0000086) | 1.88614725 |
| 118 | Fragile skin (HP:0001030) | 1.87599537 |
| 119 | Protruding ear (HP:0000411) | 1.87208063 |
| 120 | Protruding tongue (HP:0010808) | 1.86581203 |
| 121 | Abnormality of serum amino acid levels (HP:0003112) | 1.86385115 |
| 122 | Midline defect of the nose (HP:0004122) | 1.86127122 |
| 123 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.85834404 |
| 124 | Abnormality of the hepatic vasculature (HP:0006707) | 1.83118886 |
| 125 | Neoplasm of the liver (HP:0002896) | 1.82885713 |
| 126 | Hyperglycinuria (HP:0003108) | 1.82376788 |
| 127 | Hypodontia (HP:0000668) | 1.82340000 |
| 128 | Abnormality of the incisor (HP:0000676) | 1.82128964 |
| 129 | Lymphangioma (HP:0100764) | 1.81483199 |
| 130 | Pulmonary artery stenosis (HP:0004415) | 1.81442728 |
| 131 | Depressed nasal tip (HP:0000437) | 1.80328305 |
| 132 | Focal segmental glomerulosclerosis (HP:0000097) | 1.80045604 |
| 133 | Blue irides (HP:0000635) | 1.79973146 |
| 134 | Abnormality of dentin (HP:0010299) | 1.79873851 |
| 135 | Patchy hypopigmentation of hair (HP:0011365) | 1.79198724 |
| 136 | Symptomatic seizures (HP:0011145) | 1.78660165 |
| 137 | Diastasis recti (HP:0001540) | 1.78473087 |
| 138 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.77651282 |
| 139 | Congenital sensorineural hearing impairment (HP:0008527) | 1.76908067 |
| 140 | Abnormality of the nasal septum (HP:0000419) | 1.76440469 |
| 141 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.75253462 |
| 142 | Osteolytic defects of the hand bones (HP:0009699) | 1.75253462 |
| 143 | Ectopia lentis (HP:0001083) | 1.74616733 |
| 144 | Menorrhagia (HP:0000132) | 1.74481827 |
| 145 | Proximal tubulopathy (HP:0000114) | 1.74406337 |
| 146 | Deep philtrum (HP:0002002) | 1.74101363 |
| 147 | Natal tooth (HP:0000695) | 1.74022020 |
| 148 | Abnormality of the prostate (HP:0008775) | 1.73836761 |
| 149 | Narrow palate (HP:0000189) | 1.73289587 |
| 150 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.72341943 |
| 151 | Limited hip movement (HP:0008800) | 1.71586859 |
| 152 | Bladder diverticulum (HP:0000015) | 1.71210036 |
| 153 | Abnormality of the ischium (HP:0003174) | 1.71102541 |
| 154 | Abnormality of nucleobase metabolism (HP:0010932) | 1.70716609 |
| 155 | Urethral obstruction (HP:0000796) | 1.70403587 |
| 156 | Generalized hypopigmentation of hair (HP:0011358) | 1.68842029 |
| 157 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.68689341 |
| 158 | Mucopolysacchariduria (HP:0008155) | 1.68689341 |
| 159 | Vitreoretinal degeneration (HP:0000655) | 1.68683925 |
| 160 | True hermaphroditism (HP:0010459) | 1.68617061 |
| 161 | Abnormality of the neuromuscular junction (HP:0003398) | 1.68567110 |
| 162 | Fatigable weakness (HP:0003473) | 1.68567110 |
| 163 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.68524185 |
| 164 | Abnormality of the acetabulum (HP:0003170) | 1.68369172 |
| 165 | Chorioretinal atrophy (HP:0000533) | 1.67483571 |
| 166 | Myotonia (HP:0002486) | 1.66166705 |
| 167 | Ectropion (HP:0000656) | 1.65346668 |
| 168 | Asymmetry of the thorax (HP:0001555) | 1.64924237 |
| 169 | Abnormal delivery (HP:0001787) | 1.64532094 |
| 170 | Nephritis (HP:0000123) | 1.64439887 |
| 171 | Mitral stenosis (HP:0001718) | 1.64185831 |
| 172 | Absent frontal sinuses (HP:0002688) | 1.64142318 |
| 173 | Gowers sign (HP:0003391) | 1.64139212 |
| 174 | Congenital hepatic fibrosis (HP:0002612) | 1.63225687 |
| 175 | Skin nodule (HP:0200036) | 1.62441826 |
| 176 | Dilatation of the ascending aorta (HP:0005111) | 1.62120485 |
| 177 | Rhizomelia (HP:0008905) | 1.61905685 |
| 178 | Ulnar bowing (HP:0003031) | 1.61092859 |
| 179 | Decreased lacrimation (HP:0000633) | 1.60846026 |
| 180 | Asymmetric septal hypertrophy (HP:0001670) | 1.60344604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TLK1 | 4.24301658 |
| 2 | MAP3K14 | 3.15772762 |
| 3 | PTK2 | 3.07878117 |
| 4 | ZAK | 2.99534650 |
| 5 | CASK | 2.96555911 |
| 6 | EPHA2 | 2.66753365 |
| 7 | INSRR | 2.65997882 |
| 8 | ERBB3 | 2.55604928 |
| 9 | SIK1 | 2.54077923 |
| 10 | MAP3K6 | 2.45107399 |
| 11 | IRAK3 | 2.39969046 |
| 12 | BRD4 | 2.37150278 |
| 13 | YES1 | 1.99731860 |
| 14 | SRPK1 | 1.97294502 |
| 15 | CAMK1D | 1.94647817 |
| 16 | LATS1 | 1.94597434 |
| 17 | RET | 1.86937626 |
| 18 | EPHA3 | 1.86482016 |
| 19 | AKT3 | 1.81722356 |
| 20 | IRAK4 | 1.80402000 |
| 21 | EIF2AK2 | 1.76652040 |
| 22 | PIK3CG | 1.75242997 |
| 23 | NUAK1 | 1.72502961 |
| 24 | FER | 1.65729647 |
| 25 | SGK2 | 1.60333249 |
| 26 | FRK | 1.57791479 |
| 27 | SIK3 | 1.52461935 |
| 28 | RIPK1 | 1.52451173 |
| 29 | FGFR3 | 1.50840674 |
| 30 | FGFR4 | 1.50671718 |
| 31 | NEK9 | 1.50493145 |
| 32 | TXK | 1.41390692 |
| 33 | MKNK2 | 1.35645823 |
| 34 | CHUK | 1.31788229 |
| 35 | PBK | 1.30954763 |
| 36 | LIMK1 | 1.29696082 |
| 37 | IRAK1 | 1.29139262 |
| 38 | KIT | 1.27524402 |
| 39 | STK38L | 1.25404335 |
| 40 | MOS | 1.25095080 |
| 41 | JAK1 | 1.24418853 |
| 42 | CAMK1G | 1.24232771 |
| 43 | CAMKK2 | 1.21274299 |
| 44 | SGK3 | 1.19777050 |
| 45 | CDK12 | 1.18271779 |
| 46 | MKNK1 | 1.17486095 |
| 47 | MYLK | 1.17256171 |
| 48 | PIK3CA | 1.17102079 |
| 49 | TIE1 | 1.17028647 |
| 50 | TYK2 | 1.16396443 |
| 51 | TTN | 1.15882713 |
| 52 | TRIB3 | 1.15438401 |
| 53 | TNIK | 1.14899244 |
| 54 | EPHB2 | 1.14447941 |
| 55 | BRSK2 | 1.13826015 |
| 56 | IKBKE | 1.08816266 |
| 57 | TEC | 1.07819607 |
| 58 | TAOK3 | 1.06654808 |
| 59 | IKBKB | 1.02062583 |
| 60 | FGFR2 | 1.01652829 |
| 61 | OBSCN | 1.01138181 |
| 62 | PRKAA2 | 0.98094621 |
| 63 | ICK | 0.96535858 |
| 64 | EEF2K | 0.94111270 |
| 65 | PNCK | 0.93967667 |
| 66 | JAK3 | 0.93713569 |
| 67 | TESK1 | 0.92946241 |
| 68 | MST1R | 0.91795958 |
| 69 | LMTK2 | 0.89862049 |
| 70 | TAOK2 | 0.88686452 |
| 71 | STK3 | 0.87798663 |
| 72 | BMPR2 | 0.87363096 |
| 73 | STK4 | 0.87255300 |
| 74 | MUSK | 0.86951358 |
| 75 | PAK4 | 0.86544833 |
| 76 | PRKD3 | 0.85983861 |
| 77 | PLK4 | 0.85527180 |
| 78 | MAPKAPK3 | 0.84922274 |
| 79 | TRPM7 | 0.83996358 |
| 80 | STK16 | 0.83606129 |
| 81 | STK10 | 0.83284109 |
| 82 | FLT3 | 0.83261240 |
| 83 | NEK6 | 0.82531801 |
| 84 | MAPK15 | 0.80695109 |
| 85 | MAP2K6 | 0.80485247 |
| 86 | ATR | 0.79945927 |
| 87 | TBK1 | 0.78538685 |
| 88 | ROCK1 | 0.78136051 |
| 89 | EPHB1 | 0.74061469 |
| 90 | SGK223 | 0.73818582 |
| 91 | SGK494 | 0.73818582 |
| 92 | LATS2 | 0.71867904 |
| 93 | PDGFRA | 0.71705502 |
| 94 | MTOR | 0.70703117 |
| 95 | ERBB4 | 0.69981414 |
| 96 | CDK3 | 0.69772122 |
| 97 | MAP2K3 | 0.68303513 |
| 98 | NLK | 0.66997044 |
| 99 | PKN2 | 0.66970087 |
| 100 | MAP3K13 | 0.66402110 |
| 101 | NTRK1 | 0.65863995 |
| 102 | PAK3 | 0.64735222 |
| 103 | CDK6 | 0.64209947 |
| 104 | IRAK2 | 0.64179455 |
| 105 | BCKDK | 0.63687430 |
| 106 | MAPK7 | 0.63397890 |
| 107 | MST4 | 0.61383694 |
| 108 | PRKCE | 0.61210765 |
| 109 | STK38 | 0.60750274 |
| 110 | OXSR1 | 0.60426301 |
| 111 | MAP2K7 | 0.59904605 |
| 112 | PAK2 | 0.58063199 |
| 113 | PRKD1 | 0.57173543 |
| 114 | PTK2B | 0.57158115 |
| 115 | PTK6 | 0.56926806 |
| 116 | CSF1R | 0.56122642 |
| 117 | GRK7 | 0.55473215 |
| 118 | FGFR1 | 0.55192979 |
| 119 | ROCK2 | 0.54986581 |
| 120 | STK39 | 0.54649576 |
| 121 | CLK1 | 0.54188112 |
| 122 | RPS6KB1 | 0.54166835 |
| 123 | MAP3K2 | 0.53973535 |
| 124 | TGFBR2 | 0.53893387 |
| 125 | GRK1 | 0.52896356 |
| 126 | PRKD2 | 0.52645018 |
| 127 | STK24 | 0.52088511 |
| 128 | IGF1R | 0.51499509 |
| 129 | CAMK4 | 0.51326869 |
| 130 | BMPR1B | 0.49667764 |
| 131 | PRKAA1 | 0.49011382 |
| 132 | MAP2K4 | 0.47312191 |
| 133 | DMPK | 0.45612710 |
| 134 | PDPK1 | 0.45564460 |
| 135 | ATM | 0.45247306 |
| 136 | INSR | 0.44569263 |
| 137 | MAP4K2 | 0.42170933 |
| 138 | PDGFRB | 0.42042866 |
| 139 | EPHA4 | 0.41708130 |
| 140 | MAPK12 | 0.41667494 |
| 141 | CDK8 | 0.41429207 |
| 142 | ILK | 0.39034858 |
| 143 | MAP2K1 | 0.38949514 |
| 144 | SGK1 | 0.37586183 |
| 145 | MAP3K7 | 0.36239708 |
| 146 | MAPK11 | 0.36199943 |
| 147 | PLK2 | 0.35429333 |
| 148 | GSK3A | 0.34311561 |
| 149 | CDC42BPA | 0.34284770 |
| 150 | BTK | 0.33959835 |
| 151 | PRKG1 | 0.33949084 |
| 152 | ERBB2 | 0.33796481 |
| 153 | MET | 0.33745984 |
| 154 | BCR | 0.33511929 |
| 155 | AKT1 | 0.33389989 |
| 156 | DDR2 | 0.33000294 |
| 157 | ADRBK1 | 0.31784998 |
| 158 | BRSK1 | 0.28870064 |
| 159 | PRKCI | 0.27918727 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.62469299 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.17620711 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.60743719 |
| 4 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.45515275 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.45130101 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.31260294 |
| 7 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.29862575 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.25160345 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.23783371 |
| 10 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.23750931 |
| 11 | Peroxisome_Homo sapiens_hsa04146 | 2.11946907 |
| 12 | Lysine degradation_Homo sapiens_hsa00310 | 2.09020194 |
| 13 | Retinol metabolism_Homo sapiens_hsa00830 | 2.08004719 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.00677977 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.96486805 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.96122779 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.89627997 |
| 18 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.88127059 |
| 19 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.87891696 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.84924424 |
| 21 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.78140352 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.74729974 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.73469909 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.70226288 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.70030740 |
| 26 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.68717559 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.64967827 |
| 28 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.62759579 |
| 29 | ABC transporters_Homo sapiens_hsa02010 | 1.62331052 |
| 30 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.61193950 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.59803310 |
| 32 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.53344375 |
| 33 | Focal adhesion_Homo sapiens_hsa04510 | 1.52892229 |
| 34 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.46168870 |
| 35 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.45920666 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.43156457 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.42897160 |
| 38 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.41033813 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.37138225 |
| 40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.36483198 |
| 41 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.35053192 |
| 42 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.31597631 |
| 43 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.29205403 |
| 44 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.29165645 |
| 45 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.27455617 |
| 46 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.27255064 |
| 47 | Other glycan degradation_Homo sapiens_hsa00511 | 1.25228749 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.19794510 |
| 49 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.14658023 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.12050089 |
| 51 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.10961616 |
| 52 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.04032065 |
| 53 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.02394998 |
| 54 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.01122048 |
| 55 | Amoebiasis_Homo sapiens_hsa05146 | 0.99105719 |
| 56 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.97690300 |
| 57 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.94923707 |
| 58 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.93203809 |
| 59 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.93192624 |
| 60 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.92739800 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88399343 |
| 62 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.84423314 |
| 63 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.83587210 |
| 64 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.82210239 |
| 65 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.81236269 |
| 66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81196194 |
| 67 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.80498783 |
| 68 | Measles_Homo sapiens_hsa05162 | 0.79610895 |
| 69 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.79601274 |
| 70 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.78857535 |
| 71 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.78554301 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.77867235 |
| 73 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.77309499 |
| 74 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.77100635 |
| 75 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.76846839 |
| 76 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.76407606 |
| 77 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.76274064 |
| 78 | Allograft rejection_Homo sapiens_hsa05330 | 0.73830045 |
| 79 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.70898979 |
| 80 | Influenza A_Homo sapiens_hsa05164 | 0.70468746 |
| 81 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.69982281 |
| 82 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.69520115 |
| 83 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.69027980 |
| 84 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.68366271 |
| 85 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.67297027 |
| 86 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.67290940 |
| 87 | Asthma_Homo sapiens_hsa05310 | 0.67213621 |
| 88 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.66556550 |
| 89 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.66401925 |
| 90 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.65438377 |
| 91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.64924039 |
| 92 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.64052292 |
| 93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62238783 |
| 94 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.61305216 |
| 95 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.57329280 |
| 96 | Malaria_Homo sapiens_hsa05144 | 0.56594413 |
| 97 | Bile secretion_Homo sapiens_hsa04976 | 0.56488456 |
| 98 | Mineral absorption_Homo sapiens_hsa04978 | 0.56319417 |
| 99 | Tight junction_Homo sapiens_hsa04530 | 0.56313422 |
| 100 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56198912 |
| 101 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.55648642 |
| 102 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.53178623 |
| 103 | Carbon metabolism_Homo sapiens_hsa01200 | 0.52778548 |
| 104 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.51370313 |
| 105 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.51101548 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50946748 |
| 107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50658357 |
| 108 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49746865 |
| 109 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.49695383 |
| 110 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.49421716 |
| 111 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49362369 |
| 112 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48993634 |
| 113 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48972866 |
| 114 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48836522 |
| 115 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.46590137 |
| 116 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.46517355 |
| 117 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46438480 |
| 118 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.46394409 |
| 119 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.45583942 |
| 120 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45317677 |
| 121 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.44206936 |
| 122 | Melanoma_Homo sapiens_hsa05218 | 0.44102344 |
| 123 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.43177021 |
| 124 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.42751333 |
| 125 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.42692767 |
| 126 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42291097 |
| 127 | Glioma_Homo sapiens_hsa05214 | 0.42097325 |
| 128 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.40667476 |
| 129 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.39116272 |
| 130 | Hepatitis C_Homo sapiens_hsa05160 | 0.38948918 |
| 131 | Insulin resistance_Homo sapiens_hsa04931 | 0.38789271 |
| 132 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.38603451 |
| 133 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.37657316 |
| 134 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.36006889 |
| 135 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.35683585 |
| 136 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.34967861 |
| 137 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.32587061 |
| 138 | Legionellosis_Homo sapiens_hsa05134 | 0.30484773 |
| 139 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.30261654 |
| 140 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.30183311 |
| 141 | Leishmaniasis_Homo sapiens_hsa05140 | 0.28909170 |
| 142 | Homologous recombination_Homo sapiens_hsa03440 | 0.28675206 |
| 143 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26424720 |
| 144 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26226252 |
| 145 | Metabolic pathways_Homo sapiens_hsa01100 | 0.26054831 |
| 146 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.25991944 |
| 147 | Adherens junction_Homo sapiens_hsa04520 | 0.24539204 |
| 148 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.24332805 |
| 149 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.22780682 |
| 150 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.21919099 |
| 151 | Circadian rhythm_Homo sapiens_hsa04710 | 0.21489491 |
| 152 | Prostate cancer_Homo sapiens_hsa05215 | 0.21285611 |

